INTRODUCTION: The role of @entity251 in health and quality of life has become increasingly visible and overtly marketed to the public. Some evidence suggests that @entity251 levels in @entity1 may be low because of a variety of reasons, including stress and environmental exposures. OBJECTIVE: This study examines trends in @entity251 prescriptions dispensed by military treatment facilities (MTFs). METHODS: We examined data from the Department of Defense Pharmacy Data Transaction Service to determine the nature of @entity342 prescriptions dispensed through MTFs from 2007 through 2011. RESULTS: The number of @entity342 prescriptions increased more than two-fold across the military from 19,494 in 2007 to 45,270 in 2011. Most prescriptions (99%) were for @entity1 . @entity342 prescription rates rose 23% per year from 2007 through 2011 (p < 0.001, CI 23-24%). The prescription rate for 35- to 44-year-olds increased more than any other age group, with annual increases averaging 33% (p < 0.001, CI 32-34%). CONCLUSION: The number of @entity342 prescriptions within MTFs rose significantly from 2007 through 2011. This is similar to rises in @entity342 prescriptions seen in civilian medical systems. Clinical indications for the sharp increase in @entity251 prescriptions are unknown, and the indications for clinically appropriate @entity251 replacement need further clarification.

Trends in XXXX Prescriptions From Military Treatment Facilities: 2007 to 2011.

@entity1 :: ('9606', 'Species') :: ['men'] @entity251 :: ('MESH:D013739', 'Chemical') :: ['testosterone'] @entity342 :: ('CHEBI:50113', 'Chemical') :: ['androgen', 'Androgen']
@entity342 :: (CHEBI:50113,Chemical) :: ['Androgen']
